Schizophrenia Research
Volume 49, Issue 3 , Pages 231-241 , 30 April 2001

Is the association between duration of untreated psychosis and outcome confounded? A two year follow-up study of first-admitted patients

  • Hélène Verdoux

      Affiliations

    • Department of Psychiatry, University Victor Segalen, Bordeaux 2, 121 rue Bechiade; 33076 Bordeaux, Cedex, France
    • Hôpital Charles Perrens, Bordeaux, France
    • Corresponding Author InformationCorresponding author. Tel.: +33-556-561732; fax: +33-556-563546
    • ,
  • Florence Liraud

      Affiliations

    • Department of Psychiatry, University Victor Segalen, Bordeaux 2, 121 rue Bechiade; 33076 Bordeaux, Cedex, France
    • Hôpital Charles Perrens, Bordeaux, France
    • ,
  • Chantal Bergey

      Affiliations

    • Hôpital Charles Perrens, Bordeaux, France
    • ,
  • François Assens

      Affiliations

    • Hôpital Charles Perrens, Bordeaux, France
    • ,
  • François Abalan

      Affiliations

    • Hôpital Charles Perrens, Bordeaux, France
    • ,
  • Jim van Os

      Affiliations

    • University of Maastricht, Maastricht, Netherlands

Received 15 February 2000 ,Accepted 27 April 2000.

References 

  1. APA. DSM-III-R. Diagnostic and Statistical Manual of Mental Disorders. third ed. revised. Washington, DC: American Psychiatric Association; 1987;
  2. APA. DSM-IV. Diagnostic and Statistical Manual of Mental Disorders. fourth ed.. Washington, DC: American Psychiatric Association; 1994;
  3. Beiser M, Erickson D, Fleming JAE, Iacono WG. Establishing the onset of psychotic illness. Am. J. Psychiatry. 1993;150:1349–1354
  4. Carbone S, Harrigan S, McGorry PD, Elkins K. Duration of untreated psychosis and 12 month outcome in first-episode psychosis: the impact of treatment approach. Acta Psychiatr. Scand. 1999;100:96–104
  5. Craig TJ, Bromet EJ, Fennig S, Tanenberg-Karant M, Lavelle J, Galambos N. Is there an association between duration of untreated psychosis and 24 month clinical outcome in a first-admission series?. Am. J. Psychiatry. 2000;157:60–66
  6. Crow TJ, McMillan JF, Johnson AL, Johnstone EC. A randomised controlled trial of prophylactic neuroleptic treatment. Br. J. Psychiatry. 1986;148:120–127
  7. Edwards J, Maude D, McGorry PD, Harrigan SM, Coks JT. Prolonged recovery in first-episode psychosis. Br. J. Psychiatry. 1998;172(Suppl. 33):107–116
  8. Endicott J, Andreasen N, Spitzer RL. Family History-Research Diagnostic Criteria. third ed.. New York: Biometrics Research, New York State Psychiatric Institute; 1978;
  9. Everitt BS. Analysis of longitudinal data. Beyond MANOVA. Br. J. Psychiatry. 1998;172:7–10
  10. Golstein H. Multilevel Models in Educational and Social Research. London: Griffin; 1987;
  11. Guy W. Assessment Manual for Psychopharmacology. National Institute of Mental Health, Early Clinical Drug Evaluation Unit; 1976;
  12. Haas GK, Sweeney JA. Premorbid and onset features of first-episode schizophrenia. Schizophr. Bull. 1992;18:373–386
  13. Häfner H, an der Heiden W, Behrens S, Gattaz WF, Hambrecht M, Löffler W, et al. Causes and consequences of the gender differences in age at onset of schizophrenia. Schizophr. Bull. 1998;24:99–113
  14. Heinrichs DW, Hanlon TE, Carpenter WT. The quality of life scale: an instrument for rating the schizophrenic deficit syndrome. Schizophr. Bull. 1984;10:388–398
  15. Kay SR, Fizbein A, Opler LA. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophr. Bull. 1987;13:261–276
  16. Kendler SK, Prescott CA. A population-based twin study of lifetime major depression in men and women. Arch. Gen. Psychiatry. 1999;56:39–44
  17. Lecrubier Y, Seehan DV, Weiller E, Amorin P, Bonora I, Seehan KH, et al. The Mini International Neuropsychiatric Interview (MINI). A short diagnostic structured interview: reliability and validity according to the CIDI. Eur. Psychiatry. 1997;12:224–231
  18. Loebel AD, Lieberman JA, Alvir JM, Mayerhoff DI, Geisler SH, Szymanski SR. Duration of psychosis and outcome in first-episode schizophrenia. Am. J. Psychiatry. 1992;149:1183–1188
  19. McGlashan TH. Duration of untreated psychosis in first-episode schizophrenia: marker or determinant of course?. Biol. Psychiatry. 1999;46:899–907
  20. McGlashan TH, Johannessen JO. Early detection and intervention with schizophrenia: rationale. Schizophr. Bull. 1996;22:201–222
  21. McGorry PD, Edwards J, Mihalopoulos C, Harrigan SM, Jackson HJ. EPPIC: an evolving system of early detection and optimal management. Schizophr. Bull. 1996;22:305–326
  22. Navarro F, van Os J, Jones P, Murray RM. Explaining sex differences in outcome in the functional psychoses. Schizophr. Res. 1996;21:161–170
  23. STATA. STATA Statistical Software: Release 6. College Station, TX: STATA Corporation; 1999;
  24. van Os J, Fahy TA, Jones P, Harvey I, Sham P, Lewis S, et al. Psychopathological syndromes in the functional psychoses. Associations with course and outcome. Psychol. Med. 1995;26:161–176
  25. van Os J, Jones P, Sham P, Bebbington P, Murray RM. Risk factors for onset and persistence of psychosis. Soc. Psychiatry Psychiatr. Epidemiol. 1998;33:596–605
  26. van Os J, Gilvarry C, Bale R, van Horn E, Tattan T, Whiter I, et al. To what extent does symptomatic improvement result in better outcome in psychotic illness?. Psychol. Med. 1999;29:1183–1195
  27. Verdoux H, Bergey C, Assens F, Abalan F, Gonzales B, Pauillac P, et al. Prediction of duration of psychosis before first admission. Eur. Psychiatry. 1998;13:346–352
  28. Verdoux H, Liraud F, Gonzales B, Assens F, Abalan F, Beaussier JP, et al. Associations between neuropsychological performances and clinical variables in first-admitted subjects with psychotic disorders. Schizophr. Res. 1999;37:197–203
  29. Verdoux H, Liraud F, Gonzales B, Assens F, Abalan F, van Os J. Suicidality and substance misuse in first-admitted subjects with psychotic disorder. Acta Psychiatr. Scand. 1999;100:389–395
  30. Waddington JL, Youssef HA, Kinsella A. Sequential cross-sectional and 10-years prospective study of severe negative symptoms in relation to duration of initially untreated psychosis in chronic schizophrenia. Psychol. Med. 1995;25:849–857
  31. WHO. WHO coordinated multi-center study on the course and outcome of schizophrenia. Geneva: World Health Organization; 1992;
  32. Wyatt RJ, Green MF, Tuma AH. Long-term morbidity associated with delayed treatment of first admission schizophrenic patients: a re-analysis of the Camarillo State Hospital data. Psychol. Med. 1997;27:261–268

PII: S0920-9964(00)00072-4

Schizophrenia Research
Volume 49, Issue 3 , Pages 231-241 , 30 April 2001

Article Tools

* Image Usage & Resolution